Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00028483 | Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer | terminated | Phase 2 | — | Seagen Inc.INDUSTRY | 1 | Oct 24, 2011 | clinicaltrials |
| NCT00532285 | Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer | terminated | Phase 2 | 44 | National Cancer Center, KoreaOTHER_GOV | 0 | Jun 23, 2011 | clinicaltrials |
| NCT00101062 |
| Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer |
| terminated |
| Phase 2 |
| — |
| University of Medicine and Dentistry of New JerseyOTHER |
| 1 |
| Jun 8, 2011 |
| clinicaltrials |
| NCT00790894 | Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT)(HIT) | terminated | Phase 2 | 64 | Hellenic Cooperative Oncology GroupOTHER | 1 | May 18, 2011 | clinicaltrials |
| NCT00193024 | Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer | terminated | Phase 2 | 90 | SCRI Development Innovations, LLCOTHER | 0 | May 3, 2011 | clinicaltrials |
| NCT00193102 | Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer | terminated | Phase 2 | 40 | SCRI Development Innovations, LLCOTHER | 0 | May 3, 2011 | clinicaltrials |
| NCT00216073 | Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer | terminated | Phase 2 | 11 | Hoosier Cancer Research NetworkOTHER | 1 | May 2, 2011 | clinicaltrials |
| NCT00522457 | Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy | terminated | Phase 2 | 19 | Neovii BiotechINDUSTRY | 2 | Apr 29, 2011 | clinicaltrials |
| NCT00892268 | Acupuncture or Medication in Reducing Pain in Postmenopausal Women With Breast Cancer and Joint Pain | terminated | Phase 2 | 68 | University of ArizonaOTHER | 0 | Apr 27, 2010 | clinicaltrials |
| NCT00036621 | A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy | terminated | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Mar 2, 2010 | clinicaltrials |
| NCT00532454 | Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen | terminated | Phase 2 | 21 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 10, 2010 | clinicaltrials |
| NCT00677326 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer | terminated | Phase 1 / Phase 2 | 1 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00678509 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00434356 | A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B) | terminated | Phase 2 | 46 | Genentech, Inc.INDUSTRY | 0 | Dec 3, 2009 | clinicaltrials |
| NCT00770354 | Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer | terminated | Phase 2 | 110 | Antisoma ResearchINDUSTRY | 1 | Aug 10, 2009 | clinicaltrials |
| NCT00465673 | Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer | terminated | Phase 2 | 2 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00452140 | Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment | terminated | Phase 2 | 40 | Neovii BiotechINDUSTRY | 5 | May 19, 2009 | clinicaltrials |
| NCT00303615 | Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer | terminated | Phase 2 | 5 | Legacy Health SystemOTHER | 1 | Oct 20, 2008 | clinicaltrials |
| NCT00162812 | Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin(TOP) | terminated | Phase 2 | 338 | Jules Bordet InstituteOTHER | 1 | Jul 18, 2008 | clinicaltrials |
| NCT00461344 | Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer | terminated | Phase 2 | 20 | SanofiINDUSTRY | 0 | Apr 3, 2008 | clinicaltrials |
| NCT00197925 | Dendritic Cell Based Therapy of Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 40 | Herlev HospitalOTHER | 1 | Jan 3, 2008 | clinicaltrials |
| NCT00215748 | Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel | terminated | Phase 2 | 40 | Geriatric Oncology ConsortiumOTHER | 1 | Nov 16, 2007 | clinicaltrials |
| NCT00225056 | Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma | terminated | Phase 2 | 43 | Oncology Specialties, AlabamaOTHER | 1 | Apr 20, 2007 | clinicaltrials |
| NCT00123877 | Study of GPX-100 in the Treatment of Metastatic Breast Cancer | terminated | Phase 2 | 40 | Gem PharmaceuticalsINDUSTRY | 2 | Jan 9, 2007 | clinicaltrials |
| NCT00395655 | Hydralazine and Valproate Added to Chemotherapy for Breast Cancer | terminated | Phase 2 | 43 | National Institute of CancerologíaOTHER_GOV | 1 | Nov 3, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Oct 24, 2011source: clinicaltrials